AbbVie Inc.
Market Cap
$333.94B
P/E Ratio
45.68
EPS
$4.86
Dividend Yield
2.82%
52-Week Range
$164.50 — $243.32
Volume
13.88K
Avg Volume
17.35K
Beta
0.47
P/E (TTM)
45.68
Forward P/E
—
PEG Ratio
1.27
P/S (TTM)
6.83
P/B (TTM)
-128.60
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-3.62%
ROA (TTM)
0.03%
ROIC
—
Gross Margin
0.73%
Operating Margin
0.27%
Net Margin
—
Debt/Equity
-21.06
Current Ratio
0.67
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.23%
EPS Growth (5Y)
+0.04%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.12%
EPS Est (This Year)
$0.00
EPS Est (Next Year)
$0.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$2.95
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.50B
Float
1.76B
Free Float %
117.26%
RSI (14)
47.25
SMA 20
$228.80
SMA 50
$224.19
SMA 200
$214.83
ATR (14)
7.61
Volatility (Week)
0.02%
Volatility (Month)
0.02%
Pattern
Doji
1 Day
+2.11%
1 Week
-1.61%
1 Month
+3.03%
3 Months
+2.34%
6 Months
+8.64%
1 Year
—
YTD
+0.43%
All-Time High
$243.32
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
LSE
IPO Date
2013-04-08
Employees
55000
CEO
Richard A. Gonzalez
Index Membership
—
Website
https://www.abbvie.com
AbbVie Inc. (0QCV.L) is a healthcare company in the drug manufacturers - general industry listed on the LSE. With a market capitalization of $333.94B, a P/E ratio of 45.68, and a dividend yield of 2.82%, 0QCV.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0QCV.L against other stocks using dozens of fundamental and technical filters.
AbbVie Inc. (0QCV.L) has a trailing twelve-month (TTM) P/E ratio of 45.68. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, AbbVie Inc. (0QCV.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
AbbVie Inc. (0QCV.L) has a market capitalization of $333.94 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
AbbVie Inc. (0QCV.L) has returned +0.43% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.